Skip to search formSkip to main contentSkip to account menu

Valtorcitabine

Known as: 3'-VAL-L-DC, L-Valine, 3'-Ester with 2'-Deoxycytidine 
An orally active prodrug of torcitabine (L-deoxycytidine), a nucleoside analog with activity against hepatitis B virus. Torcitabine is modified in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
OBJECTIVE The review covers basic principles of the prodrug strategy applied to antiviral nucleoside drugs or drug candidates… 
Review
2007
Review
2007
Review
2005
Review
2005
  • R. Gish
  • Seminars in liver disease (Print)
  • 2005
  • Corpus ID: 45683359
Currently approved treatments for chronic infection with hepatitis B virus (HBV) are limited by low rates of sustained response… 
Review
2004
Review
2004
  • R. A. V. Hodge
  • Current opinion in investigational drugs
  • 2004
  • Corpus ID: 33887010
Idenix (formerly Novirio) and Novartis are developing two beta-L-deoxynucleosides, telbivudine and torcitabine, for the potential…